Horizon Technology Finance Corporation filings document a specialty finance issuer focused on debt investments and related warrant and equity positions in technology, life science, healthcare information and services, and sustainability companies. Recent 8-K filings record operating and financial results, board-declared regular and special distributions, shareholder voting matters, and capital-structure details for common stock and the 6.25% Notes due 2027.
The filing record also documents material agreements and corporate actions, including the completed Monroe Capital Corporation merger and the HRZN CRFH LLC joint venture, along with governance and investment-committee arrangements relevant to those events.
Horizon Technology Finance Corporation and Monroe Capital Corporation filed Supplement No. 2 to their Joint Proxy Statement/Prospectus updating disclosures about the proposed asset sale and merger and announcing enhanced near-term cash distributions. The supplement describes a Supplemental MRCC Distribution of $13.0 million and proposed HRZN Supplemental Distributions to use undistributed taxable earnings for two quarters following closing, subject to board declaration and closing conditions.
The supplement also discloses that following HRZN’s March 3, 2026 announcement of a reduced quarterly distribution of $0.18 per share, HRZN’s closing price fell from $6.11 to $4.69 on March 4, 2026, and MRCC’s closing price fell from $6.03 to $4.84 on March 4, 2026. The supplement states the Special Committees and Boards supported announcing the supplemental distributions and describes related fiduciary deliberations and tax treatment of the Supplemental MRCC Distribution.
Horizon Technology Finance Corporation is issuing supplemental disclosures about its planned merger with Monroe Capital Corporation after three shareholder lawsuits challenged the adequacy of the joint proxy statement. The suits allege the proxy omitted material details and seek additional disclosure and to block closing.
HRZN denies any wrongdoing but is voluntarily expanding the proxy to include detailed prospective financial information for MRCC, HRZN, and the combined company. These internal forecasts show estimated annual net investment income per share and dividends for 2026–2030, plus projected net asset value per share, with combined-company projections reflecting assumed cost savings from the merger.
HRZN also updates disclosure about prior and potential future engagements of its financial advisor Oppenheimer with HRZN, MRCC, their affiliates, and other transaction participants. A special committee of independent directors and the full board unanimously continue to recommend that stockholders vote “FOR” the merger stock issuance and related director election proposals at the March 13, 2026 special meeting.
Horizon Technology Finance Corporation filed Supplement No. 1 dated March 5, 2026 to the joint proxy statement/prospectus dated January 16, 2026. The supplement amends, supplements or modifies information in the combined prospectus and definitive joint proxy statement of HRZN and Monroe Capital Corporation.
The supplement incorporates by reference previously filed SEC documents and states that the Joint Proxy Statement/Prospectus is available free of charge at www.sec.gov or via the HRZN and MRCC investor relations contact details provided in the text.
Horizon Technology Finance Corporation filed its annual report as a business development company focused on secured venture loans to technology, life science, healthcare information and services, and sustainability companies. As of December 31, 2025, the debt portfolio held 38 investments with aggregate fair value of $596.0 million, and net assets of $318.5 million.
For 2025, the dollar-weighted annualized yield on average debt investments was 15.8%, with an overall portfolio yield of 14.6%, while total return based on market value was (13.6)%. As of March 3, 2026, there were 47,804,711 shares of common stock outstanding. The company describes a pending multi‑step transaction in which Monroe Capital Income Plus Corporation will acquire Monroe Capital Corporation’s investment assets and liabilities for cash, followed by a merger that would ultimately leave Horizon as the surviving entity. The filing also details a 2025 change of control of its external advisor to an affiliate of Wendel SE, the approval of a new investment management agreement, and several senior management transitions, while affirming continued adherence to its venture lending strategy and regulated investment company tax status.
Horizon Technology Finance Corporation announced that its board has declared monthly cash distributions of $0.06 per share, to be paid in April, May and June 2026, for a total of $0.18 per share. The payments are scheduled for April 15, May 15 and June 16, 2026 to stockholders of record on March 16, April 16 and May 18, 2026, respectively.
The board sets distribution levels each quarter based on results of operations, spillover income and its longer-term outlook, including the expected impact of the anticipated merger with Monroe Capital Corporation. The company notes it has paid $360 million in distributions since its 2010 initial public offering and maintains a Dividend Reinvestment Plan that automatically reinvests distributions in additional shares for stockholders who do not opt out.
Horizon Technology Finance reported fourth quarter 2025 net investment income of $8.3 million, or $0.18 per share, on total investment income of $20.7 million, as a smaller debt portfolio and lower prepayments reduced revenue. Net realized losses on investments were $23.3 million, but this was offset by $24.7 million of net unrealized appreciation, leading to a modest net increase in net assets from operations of $0.20 per share.
For full year 2025, net investment income was $44.4 million, or $1.05 per share, down from $1.32 per share in 2024, while net realized losses on investments widened to $55.1 million. Net asset value fell to $6.98 per share at December 31, 2025, from $8.43 a year earlier. The debt portfolio carried a fair value of $596.0 million with a 14.3% yield in the quarter, and committed backlog reached $154 million. Horizon ended the year with $189.2 million of available liquidity and a net debt-to-equity leverage ratio of 105%, and its board declared monthly distributions of $0.06 per share for April, May and June 2026 while progressing toward a planned merger with Monroe Capital Corporation.
Horizon Technology Finance Corporation reported that its wholly owned subsidiary, Horizon Credit II LLC, entered into two new amendments to existing financing arrangements with KeyBank National Association and related parties. On February 6, 2026, Horizon Credit II LLC executed Amendment No. 3 to the Second Amended and Restated Loan and Security Agreement with KeyBank and the lenders. On February 10, 2026, Horizon Credit II LLC and Horizon Technology Finance Corporation executed Amendment No. 3 to the Second Amended and Restated Sale and Servicing Agreement involving Horizon Technology Finance Management LLC, U.S. Bank National Association, and KeyBank. The company filed these amendments as exhibits, indicating ongoing updates to its secured loan and servicing structures.
Horizon Technology Finance Corp. has had its 4.875% Notes due 2026 removed from listing and registration on the New York Stock Exchange. The Exchange filed a Form 25, certifying that it met the requirements of Section 12(b) of the Securities Exchange Act and related Rule 12d2-2.
Horizon Technology Finance Corporation and Monroe Capital Corporation are asking stockholders to approve a two‑step transaction in which MRCC will first sell all of its investment assets for cash to Monroe Capital Income Plus Corporation, then merge into HRZN, with HRZN as the surviving BDC.
MRCC will receive cash equal to the fair value of its assets, use it to repay liabilities and distribute undistributed net investment income, then MRCC stockholders will receive HRZN common stock based on a NAV‑driven exchange ratio calculated shortly before closing, with cash paid instead of fractional shares. Separate special meetings on March 13, 2026 will seek HRZN stockholder approval of issuing HRZN shares for the merger and electing one Class I director, and MRCC stockholder approval of both the asset sale and the merger; each board, following independent special committee review and financial advisor opinions, unanimously recommends voting in favor of its respective proposals. The HRZN adviser has agreed to a $4.0 million management and incentive fee waiver over four quarters after closing, and the merger is intended to be tax‑free for MRCC stockholders except for cash in lieu of fractional shares.